Items where authors include "Merola, JF"

Export as [feed] Atom [feed] RSS
Number of items: 5.

Article

Coates, LC, Merola, JF, Mease, PJ et al. (10 more authors) (2020) Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis. Rheumatology. keaa271. ISSN 1462-0324

Coates, LC orcid.org/0000-0002-4756-663X, FitzGerald, O, Merola, JF et al. (23 more authors) (2018) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis. Arthritis & Rheumatology, 70 (3). pp. 345-355. ISSN 2326-5191

Favier, G, Gladman, DD, Merola, JF et al. (3 more authors) (2017) Benchmarking Care in Psoriatic Arthritis — The QUANTUM Report: A Report from the GRAPPA 2016 Annual Meeting. The Journal of Rheumatology, 44 (5). pp. 674-678. ISSN 0315-162X

Conference or Workshop Item

Merola, JF, Gottlieb, AB, Mease, P et al. (5 more authors) (2020) Psoriasis outcomes in a randomized trial of etanercept and methotrexate as monotherapy or in combination in patients with psoriatic arthritis. In: 2020 AAD VMX, 12-14 Jun 2020, Virtual.

Proceedings Paper

Merola, JF, Coates, LC, Husni, ME et al. (3 more authors) (2018) Ixekizumab reduces disease activity up to 52 weeks in active psoriatic arthritis patients with inadequate response to tumor necrosis factor inhibitors: An assessment with the use of minimal disease activity scores. In: Journal of the American Academy of Dermatology. American Academy of Dermatology 2018 Annual Meeting, 16-20 Feb 2018, San Diego, California, USA. Elsevier , AB174-AB174.

This list was generated on Sun Mar 24 08:24:32 2024 GMT.